Serial Number | 97510241 |
Word Mark | HARBOUR HCAB PLUS |
Filing Date | Tuesday, July 19, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, August 24, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor |
Goods and Services | Technical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; medical research; biological research; Biochemical research and analysis; Testing of pharmaceuticals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 9, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, August 9, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Harbour Antibodies U.S., Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | NEWTON, MA 02458 |
Event Date | Event Description |
Thursday, August 24, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, August 24, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Thursday, August 24, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, May 10, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 10, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, May 10, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, May 3, 2023 | ASSIGNED TO EXAMINER |
Tuesday, August 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, July 22, 2022 | NEW APPLICATION ENTERED |